Gilead wins positive data in coronavirus treatment study


Gilead Sciences (BROWN) – Get a report Stocks climbed higher on Friday after the drug maker released new data touting the effectiveness of its treatment for coronaviruses.Gilead said that patients treated with remdesivir, an experimental antiviral for the treatment of COVID-19, showed improved recoveries in the phase III study, with a 62% reduction in mortality rates. Gilead said the comparative results of the trial showed that 74.4% of patients treated with remdesivir recovered from the virus on day 14, while the figure for those receiving standard care showed a recovery rate of 59 %.


Please enter your comment!
Please enter your name here